Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
VMD · Nasdaq · United States · Services-Misc Health & Allied Services, Nec
In shortVIEMED HEALTHCARE, INC. is profitable, generates cash and holds more cash than debt, with revenue growing (+20.5% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 8.5% | 45/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 5.5% | 42/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 10.9% | 55/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 10.5% | 70/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.18× | 32/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.09× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 5.38 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 4.4% | 38/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.80× | 62/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 16.1% | 51/100 |
| Operating margin volatility | 1.4% | 96/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 24.9% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | 32.2% | 100/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 117 | 139 | 183 | 224 | 270 |
| Cost of revenue | 44 | 54 | 70 | 91 | 115 |
| Gross profit | 73 | 85 | 113 | 133 | 155 |
| Research & development | 2.1 | 2.7 | 2.8 | 3.1 | 3 |
| Selling, general & admin | 55 | 68 | 88 | 106 | 121 |
| Operating income | 12 | 8.3 | 14 | 18 | 23 |
| Pre-tax income | 13 | 9 | 14 | 16 | 22 |
| Income tax | 3.4 | 2.8 | 4.1 | 4.8 | 6.4 |
| Net income | 9.1 | 6.2 | 10 | 11 | 15 |
| Diluted EPS | $0.22 | $0.16 | $0.25 | $0.28 | $0.37 |
| Diluted shares (millions) | 41 | 40 | 40 | 41 | 41 |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
5.38 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 3, 2026